Home

Kleben Beleben Postkarte met inhibitor Verdreifachen An Bord Sein

c-Met inhibitor - Wikipedia
c-Met inhibitor - Wikipedia

The role of MET in chemotherapy resistance | Oncogene
The role of MET in chemotherapy resistance | Oncogene

c-Met inhibitor - Wikipedia
c-Met inhibitor - Wikipedia

Developing c-MET pathway inhibitors for cancer therapy: progress and challenges: Trends in Molecular Medicine
Developing c-MET pathway inhibitors for cancer therapy: progress and challenges: Trends in Molecular Medicine

Safety and Tolerability of c-MET Inhibitors in Cancer | SpringerLink
Safety and Tolerability of c-MET Inhibitors in Cancer | SpringerLink

Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR-mutant lung cancer | Science Translational Medicine
Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR-mutant lung cancer | Science Translational Medicine

c-Met inhibitor - Wikipedia
c-Met inhibitor - Wikipedia

Discovery of Potent, Selective Triazolothiadiazole-Containing c-Met Inhibitors | ACS Medicinal Chemistry Letters
Discovery of Potent, Selective Triazolothiadiazole-Containing c-Met Inhibitors | ACS Medicinal Chemistry Letters

MET Signaling: Novel Targeted Inhibition and Its Clinical Development in Lung Cancer - ScienceDirect
MET Signaling: Novel Targeted Inhibition and Its Clinical Development in Lung Cancer - ScienceDirect

PDF] EGFR and c-Met Inhibitors are Effective in Reducing Tumorigenicity in Cancer | Semantic Scholar
PDF] EGFR and c-Met Inhibitors are Effective in Reducing Tumorigenicity in Cancer | Semantic Scholar

PDF] Single-Agent and Combination Therapeutic Strategies to Inhibit Hepatocyte Growth Factor/MET Signaling in Cancer | Semantic Scholar
PDF] Single-Agent and Combination Therapeutic Strategies to Inhibit Hepatocyte Growth Factor/MET Signaling in Cancer | Semantic Scholar

MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer | Journal of Hematology & Oncology | Full Text
MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer | Journal of Hematology & Oncology | Full Text

Molecules | Free Full-Text | Design, Synthesis, and Biological Evaluation of Pyridineamide Derivatives Containing a 1,2,3-Triazole Fragment as Type II c-Met Inhibitors
Molecules | Free Full-Text | Design, Synthesis, and Biological Evaluation of Pyridineamide Derivatives Containing a 1,2,3-Triazole Fragment as Type II c-Met Inhibitors

cに応じられた阻害 | c-Met Inhibition
cに応じられた阻害 | c-Met Inhibition

Type II c-Met inhibitors: molecular insight into crucial interactions for effective inhibition | SpringerLink
Type II c-Met inhibitors: molecular insight into crucial interactions for effective inhibition | SpringerLink

AMG-458 is a Selective and Orally Bioavailable c-Met Inhibitor - Network of Cancer Research
AMG-458 is a Selective and Orally Bioavailable c-Met Inhibitor - Network of Cancer Research

Trends in the development of MET inhibitors for hepatocellular carcinoma | Future Oncology
Trends in the development of MET inhibitors for hepatocellular carcinoma | Future Oncology

HGF-MET inhibitors and potential sites of action. Abbreviations: HGF,... | Download Scientific Diagram
HGF-MET inhibitors and potential sites of action. Abbreviations: HGF,... | Download Scientific Diagram

Discovery of Potent, Selective Triazolothiadiazole-Containing c-Met Inhibitors | ACS Medicinal Chemistry Letters
Discovery of Potent, Selective Triazolothiadiazole-Containing c-Met Inhibitors | ACS Medicinal Chemistry Letters

MET Inhibition in Non-Small Cell Lung Cancer - European Medical Journal
MET Inhibition in Non-Small Cell Lung Cancer - European Medical Journal

The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping - Cancer Treatment Reviews
The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping - Cancer Treatment Reviews

c-Met inhibitor - Wikipedia
c-Met inhibitor - Wikipedia

Frontiers | Selective Inhibitor of the c-Met Receptor Tyrosine Kinase in Advanced Hepatocellular Carcinoma: No Beneficial Effect With the Use of Tivantinib?
Frontiers | Selective Inhibitor of the c-Met Receptor Tyrosine Kinase in Advanced Hepatocellular Carcinoma: No Beneficial Effect With the Use of Tivantinib?

Imidazopyridine hydrazone derivatives exert antiproliferative effect on lung and pancreatic cancer cells and potentially inhibit receptor tyrosine kinases including c-Met | Scientific Reports
Imidazopyridine hydrazone derivatives exert antiproliferative effect on lung and pancreatic cancer cells and potentially inhibit receptor tyrosine kinases including c-Met | Scientific Reports